Canaccord Genuity Group assumed coverage on shares of Waldencast (NASDAQ:WALD – Free Report) in a research report report published on Friday morning, Marketbeat reports. The brokerage issued a buy rating and a $5.00 price objective on the stock.
A number of other research firms have also issued reports on WALD. Telsey Advisory Group reissued an “outperform” rating and issued a $6.00 target price on shares of Waldencast in a report on Wednesday, October 9th. DA Davidson boosted their target price on Waldencast from $6.50 to $7.25 and gave the company a “buy” rating in a report on Wednesday, September 4th.
Read Our Latest Stock Report on WALD
Waldencast Trading Up 3.3 %
Institutional Trading of Waldencast
A number of institutional investors have recently modified their holdings of WALD. Marshall Wace LLP purchased a new stake in shares of Waldencast in the second quarter valued at approximately $37,000. McAdam LLC purchased a new stake in shares of Waldencast in the third quarter valued at approximately $62,000. Catalina Capital Group LLC purchased a new stake in shares of Waldencast in the first quarter valued at approximately $73,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Waldencast in the second quarter valued at approximately $85,000. Finally, Norden Group LLC purchased a new stake in shares of Waldencast in the first quarter valued at approximately $92,000. 41.97% of the stock is currently owned by hedge funds and other institutional investors.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Articles
- Five stocks we like better than Waldencast
- What Makes a Stock a Good Dividend Stock?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What is the Australian Securities Exchange (ASX)
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.